Baylor Genetics provides precision diagnostics through comprehensive genetic testing and genomic analysis. The company operates a diagnostic genomics platform offering a suite of tests, including whole genome sequencing, whole exome sequencing, RNA sequencing, and chromosomal microarray analysis, along with specialized assays. It has performed over 4 million tests worldwide.
The company's work spans several medical domains, including rare diseases, pediatric genetics, reproductive health, hereditary cancer, and metabolic disorders. Its technical capabilities encompass a range of advanced genomic methodologies, from single-gene assays to multiomics analysis.